Bioequivalent Products
In conformity with DYNAPHARM's policy of always maintaining optimum safety and efficacy standards, the company consistently sends its selected products for Bioequivalent Studies as required by the Malaysian Ministry of Health.
Such studies conducted by an accredited Research Centre, serves to compare the Generic Products under study with the Proprietary Product. Dynapharm has so far sent 7 products for study, all of which passed the requirements of the tests and were certified acceptable. The 7 products as shown below:
| Product Name | Compare with | Contents | Dosage Forms | Summary Study Report |
|---|---|---|---|---|
| DYNORMIN | TENORMIN from Astrazeneca |
Atenolol | Tablet | Download PDF |
| DYNAMET | TAGAMET from Glaxosmithkline |
Cimetidine | Tablet | Download PDF |
| METFORMIN | GLUCOPHAGE from Lipha/ Merck |
Metformin | Tablet | Download PDF |
| DYANIL | DAONIL from Aventis Farma |
Glibenclamide | Tablet | Download PDF |
| CIPROFLOXACIN | CIPROBAY from Bayer |
Ciprofloxacin | Capsule | Download PDF |
| KETOCONAZOLE | NIZORAL from Janssen-Cilag |
Ketoconazole | Tablet | Download PDF |
| TICLOPIDINE | Ticlid® from Sanofi-Adventis |
Ticlopidine | Tablet | Download PDF |